Adam J Spanier1, Robert S Kahn2, Allen R Kunselman3, Eric W Schaefer3, Richard Hornung2, Yingying Xu2, Antonia M Calafat4, Bruce P Lanphear5. 1. Department of Pediatrics, Penn State University Hershey Medical Center, Hershey, Pennsylvania2Department of Public Health Sciences, Penn State University Hershey Medical Center, Hershey, Pennsylvania3currently with the Department of Pediatrics, University. 2. Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 3. Department of Public Health Sciences, Penn State University Hershey Medical Center, Hershey, Pennsylvania. 4. Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia. 5. Child and Family Research Institute, British Columbia Children's Hospital and Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada.
Abstract
IMPORTANCE: Bisphenol A (BPA), a prevalent endocrine-disrupting chemical, has been associated with wheezing in children, but few studies have examined its effect on lung function or wheeze in older children. OBJECTIVES: To test whether BPA exposure is associated with lung function, with wheeze, and with pattern of wheeze in children during their first 5 years. DESIGN, SETTING, AND PARTICIPANTS: A birth cohort study, enrolled during early pregnancy in the greater Cincinnati, Ohio, area among 398 mother-infant dyads. We collected maternal urine samples during pregnancy (at 16 and 26 weeks) and child urine samples annually to assess gestational and child BPA exposure. MAIN OUTCOMES AND MEASURES: We assessed parent-reported wheeze every 6 months for 5 years and measured child forced expiratory volume in the first second of expiration (FEV1) at age 4 and 5 years. We evaluated associations of BPA exposure with respiratory outcomes, including FEV1, child wheeze, and wheeze phenotype. RESULTS: Urinary BPA concentrations and FEV1 data were available for 208 children and urinary BPA concentrations and parent-reported wheeze data were available for 360 children. The mean maternal urinary BPA concentration ranged from 0.53 to 293.55 µg/g of creatinine. In multivariable analysis, every 10-fold increase in the mean maternal urinary BPA concentration was associated with a 14.2% (95% CI, -24.5% to -3.9%) decrease in the percentage predicted FEV1 at 4 years, but no association was found at 5 years. In multivariable analysis, every 10-fold increase in the mean maternal urinary BPA concentration was marginally associated with a 54.8% increase in the odds of wheezing (adjusted odds ratio, 1.55; 95% CI, 0.91-2.63). While the mean maternal urinary BPA concentration was not associated with wheeze phenotype, a 10-fold increase in the 16-week maternal urinary BPA concentration was associated with a 4.27-fold increase in the odds of persistent wheeze (adjusted odds ratio, 4.27; 95% CI, 1.37-13.30). Child urinary BPA concentrations were not associated with FEV1 or wheeze. CONCLUSIONS AND RELEVANCE: These results provide evidence suggesting that prenatal but not postnatal exposure to BPA is associated with diminished lung function and the development of persistent wheeze in children.
IMPORTANCE: Bisphenol A (BPA), a prevalent endocrine-disrupting chemical, has been associated with wheezing in children, but few studies have examined its effect on lung function or wheeze in older children. OBJECTIVES: To test whether BPA exposure is associated with lung function, with wheeze, and with pattern of wheeze in children during their first 5 years. DESIGN, SETTING, AND PARTICIPANTS: A birth cohort study, enrolled during early pregnancy in the greater Cincinnati, Ohio, area among 398 mother-infant dyads. We collected maternal urine samples during pregnancy (at 16 and 26 weeks) and child urine samples annually to assess gestational and childBPA exposure. MAIN OUTCOMES AND MEASURES: We assessed parent-reported wheeze every 6 months for 5 years and measured child forced expiratory volume in the first second of expiration (FEV1) at age 4 and 5 years. We evaluated associations of BPA exposure with respiratory outcomes, including FEV1, child wheeze, and wheeze phenotype. RESULTS: Urinary BPA concentrations and FEV1 data were available for 208 children and urinary BPA concentrations and parent-reported wheeze data were available for 360 children. The mean maternal urinary BPA concentration ranged from 0.53 to 293.55 µg/g of creatinine. In multivariable analysis, every 10-fold increase in the mean maternal urinary BPA concentration was associated with a 14.2% (95% CI, -24.5% to -3.9%) decrease in the percentage predicted FEV1 at 4 years, but no association was found at 5 years. In multivariable analysis, every 10-fold increase in the mean maternal urinary BPA concentration was marginally associated with a 54.8% increase in the odds of wheezing (adjusted odds ratio, 1.55; 95% CI, 0.91-2.63). While the mean maternal urinary BPA concentration was not associated with wheeze phenotype, a 10-fold increase in the 16-week maternal urinary BPA concentration was associated with a 4.27-fold increase in the odds of persistent wheeze (adjusted odds ratio, 4.27; 95% CI, 1.37-13.30). Child urinary BPA concentrations were not associated with FEV1 or wheeze. CONCLUSIONS AND RELEVANCE: These results provide evidence suggesting that prenatal but not postnatal exposure to BPA is associated with diminished lung function and the development of persistent wheeze in children.
Authors: H Eigen; H Bieler; D Grant; K Christoph; D Terrill; D K Heilman; W T Ambrosius; R S Tepper Journal: Am J Respir Crit Care Med Date: 2001-03 Impact factor: 21.405
Authors: Kathleen M Donohue; Rachel L Miller; Matthew S Perzanowski; Allan C Just; Lori A Hoepner; Srikesh Arunajadai; Stephen Canfield; David Resnick; Antonia M Calafat; Frederica P Perera; Robin M Whyatt Journal: J Allergy Clin Immunol Date: 2013-03 Impact factor: 10.793
Authors: Antonia M Calafat; Xiaoyun Ye; Lee-Yang Wong; John A Reidy; Larry L Needham Journal: Environ Health Perspect Date: 2008-01 Impact factor: 9.031
Authors: Laura S Van Winkle; Shannon R Murphy; Miriam V Boetticher; Catherine A VandeVoort Journal: Environ Health Perspect Date: 2013-06-11 Impact factor: 9.031
Authors: Joseph M Braun; Geetika Kalloo; Aimin Chen; Kim N Dietrich; Stacey Liddy-Hicks; Samantha Morgan; Yingying Xu; Kimberly Yolton; Bruce P Lanphear Journal: Int J Epidemiol Date: 2017-02-01 Impact factor: 7.196
Authors: Angelico Mendy; Pӓivi M Salo; Jesse Wilkerson; Lydia Feinstein; Kelly K Ferguson; Michael B Fessler; Peter S Thorne; Darryl C Zeldin Journal: Environ Res Date: 2019-11-22 Impact factor: 6.498
Authors: Kimberly Berger; Eric Coker; Stephen Rauch; Brenda Eskenazi; John Balmes; Katie Kogut; Nina Holland; Antonia M Calafat; Kim Harley Journal: Sci Total Environ Date: 2020-04-03 Impact factor: 7.963
Authors: S M J MohanKumar; T D Rajendran; A K Vyas; V Hoang; N Asirvatham-Jeyaraj; A Veiga-Lopez; N B Olivier; V Padmanabhan; P S MohanKumar Journal: J Dev Orig Health Dis Date: 2016-11-04 Impact factor: 2.401
Authors: Jessie P Buckley; Lesliam Quirós-Alcalá; Susan L Teitelbaum; Antonia M Calafat; Mary S Wolff; Stephanie M Engel Journal: Environ Int Date: 2018-03-20 Impact factor: 9.621
Authors: Robert B Gunier; Rachel Raanan; Rosemary Castorina; Nina T Holland; Kim G Harley; John R Balmes; Laura Fouquette; Brenda Eskenazi; Asa Bradman Journal: Environ Res Date: 2018-02-23 Impact factor: 6.498